Novartis appeals IP win for Pharmacor over blood pressure drug
SYDNEY: Pharmaceutical giant Novartis is challenging the loss of its case against generics company Pharmacor
SYDNEY: Pharmaceutical giant Novartis is challenging the loss of its case against generics company Pharmacor